Selected Publications

Forner A, Da Fonseca LG, Díaz-González Á, Sanduzzi-Zamparelli M, Reig M, Bruix J. Controversies in the management of hepatocellular carcinoma. JHEP Rep. 2019 Mar 18;1(1):17-29. PMID: 32039350; PMCID: PMC7001551.
doi: 10.1016/j.jhepr.2019.02.003 

Da Fonseca LG, Hashizume PH, de Oliveira IS, Izquierdo-Sanchez L, Saud LRDC, Xerfan MP, Alves VAF, de Mello ES, Herman P, Banales JM, Oliveira CP, Carrilho FJ. Association between Metabolic Disorders and Cholangiocarcinoma: Impact of a Postulated Risk Factor with Rising Incidence. Cancers (Basel). 2022 Jul 18;14(14):3483. PMID: 35884542; PMCID: PMC9323381.
doi: 10.3390/cancers14143483 

Díaz-González Á, Sanduzzi-Zamparelli M, Sapena V, Torres F, LLarch N, Iserte G, Forner A, da Fonseca L, Ríos J, Bruix J, Reig M. Systematic review with meta-analysis: the critical role of dermatological events in patients with hepatocellular carcinoma treated with sorafenib. Aliment Pharmacol Ther. 2019 Mar;49(5):482-491. Epub 2019 Jan 29. PMID: 30695819.
doi: 10.1111/apt.15088 

da Fonseca LG, Reig M, Bruix J. Tyrosine Kinase Inhibitors and Hepatocellular Carcinoma. Clin Liver Dis. 2020 Nov;24(4):719-737. Epub 2020 Sep 28. PMID: 33012455.
doi: 10.1016/j.cld.2020.07.012 

Bruix J, da Fonseca LG, Reig M. Insights into the success and failure of systemic therapy for hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2019 Oct;16(10):617-630. Epub 2019 Aug 1. PMID: 31371809.
doi: 10.1038/s41575-019-0179-x